Filing Details
- Accession Number:
- 0001127602-22-006332
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-23 16:40:33
- Reporting Period:
- 2022-02-18
- Accepted Time:
- 2022-02-23 16:40:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1730048 | C. Craig Hopkinson | 852 Winter St. Waltham MA 02451 | Evp R&D, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-02-18 | 2,306 | $25.17 | 9,496 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2022-02-20 | 10,096 | $0.00 | 19,592 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-02-20 | 2,966 | $25.08 | 16,626 | No | 4 | F | Direct | |
| Ordinary Shares | Acquisiton | 2022-02-21 | 6,875 | $0.00 | 23,501 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-02-21 | 2,022 | $25.08 | 21,479 | No | 4 | F | Direct | |
| Ordinary Shares | Acquisiton | 2022-02-22 | 12,037 | $0.00 | 33,516 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-02-22 | 3,539 | $25.01 | 29,977 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (Right to Buy) | Acquisiton | 2022-02-18 | 139,554 | $0.00 | 139,554 | $25.08 |
| Ordinary Shares | Restricted Stock Unit Award | Acquisiton | 2022-02-18 | 34,889 | $0.00 | 34,889 | $0.00 |
| Ordinary Shares | Restricted Stock Unit Award | Disposition | 2022-02-20 | 10,096 | $0.00 | 10,096 | $0.00 |
| Ordinary Shares | Restricted Stock Unit Award | Disposition | 2022-02-21 | 6,875 | $0.00 | 6,875 | $0.00 |
| Ordinary Shares | Restricted Stock Unit Award | Disposition | 2022-02-22 | 12,037 | $0.00 | 12,037 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 139,554 | 2032-02-18 | No | 4 | A | Direct | |
| 34,889 | No | 4 | A | Direct | ||
| 20,191 | No | 4 | M | Direct | ||
| 6,875 | No | 4 | M | Direct | ||
| 36,114 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Restricted stock units convert into ordinary shares on a one-for-one basis.
- Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
- Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/18/2023.
- Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021.
- Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020.
- Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022.
Billionaire Hedge Funds
